CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Onduo Appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03865381
NCT03865381N/ACompleted
CompareCT.gov

Onduo Virtual Diabetes Clinic Study

Verily Life Sciences LLC·interventional·Posted Mar 6, 2019·Updated Sep 24, 2021

In Brief

A clinical study evaluating Onduo App for Diabetes Mellitus, Type 2. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

This is a prospective, single arm study designed to evaluate the change in hemoglobin A1c after 4 months of participation in the Onduo Virtual Diabetes Clinic (VDC) in individuals with Type 2 diabetes and suboptimal glycemic control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 6, 2019
Enrollment StartFeb 8, 2019
Primary CompletionFeb 12, 2020
Study CompletionOct 15, 2020
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 7.3 years ago

Interventions

Onduo Appdevice

The Onduo App is a software application which tracks data relevant to diabetes care, such as, but not limited to, medication, meal logs and glucose readings, and activity data. The Onduo App connects wirelessly to a Care Team Console through the Internet. The Onduo App may also connect wirelessly to commercially available FDA-regulated (i.e., cleared and approved) medical devices and non-medical devices through the subject's Smartphone.